Baird’s iShares Biotechnology ETF IBB Stock Holding History

Baird’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$3.23M	Buy	28,221 +2,532	+10%	+$279K	0.03%	432
2014 Q4	$2.6M	Sell	25,689 -2,211	-8%	-$215K	0.03%	482
2014 Q3	$2.54M	Buy	27,900 +468	+2%	+$41.1K	0.04%	406
2014 Q2	$2.35M	Buy	27,432 +3,570	+15%	+$281K	0.03%	443
2014 Q1	$1.88M	Sell	23,862 -10,362	-30%	-$863K	0.03%	482
2013 Q4	$2.59M	Buy	34,224 +10,092	+42%	+$716K	0.04%	403
2013 Q3	$1.69M	Sell	24,132 -915	-4%	-$59.9K	0.03%	474
2013 Q2	$1.45M	Buy	+25,047	New	+$1.45M	0.03%	479

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BFA

Beaumont Financial Advisors Needham, Massachusetts $1.57B AUM 25.77% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Baird's IBB Position: Q1 2015 in Review

Baird increased its iShares Biotechnology ETF (IBB) stake by 9.9% in Q1 2015, buying an estimated $279K and bringing the position to 28,221 shares worth $3.23M. The position accounts for 0.03% of the portfolio, ranked #432.

Baird first reported a position in IBB in Q2 2013 and has held it in 8 quarters since. 400 funds tracked by Wall St. Rank hold IBB as of Q1 2015.

Baird held 28,221 shares of iShares Biotechnology ETF worth $3.23M as of Q1 2015.
Baird bought 2,532 iShares Biotechnology ETF shares in Q1 2015, an estimated $279K.
iShares Biotechnology ETF made up 0.03% of Baird's portfolio in Q1 2015, its #432 holding.
Baird first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 8 quarters since.
400 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.